The incidence risk of breast and gynecological cancer by antidepressant use: A systematic review and dose–response meta-analysis of epidemiological studies involving 160,727 patients

The incidence risk of breast and gynecological cancer by antidepressant use: A systematic review and dose–response meta-analysis of epidemiological studies involving 160,727 patients

Background and objectiveAntidepressants are widely prescribed to treat depression and anxiety disorders that may become chronic conditions among women. Epidemiological studies have yielded inconsistent results on the correlation between antidepressant use and the incidence risk of female breast and...

Full description

Bibliographic Details
Main Authors: Yanjia Zhuang, Xiaogang Pang, Yuchen Qi, Tianshu Zhang, Guimao Cao, Heming Xue, Yifan Xu, Shuoxin Xie, Yifan Liu, Yinuo Wang, Yunxiao Li, Ying Xiong, Yuanyuan Li, Hui Shen
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Oncology
Subjects:
antidepressant
depression
breast cancer
gynecological cancer
incidence
meta-analysis
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.939636/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.939636/full

Similar Items